Antithrombotic Preventive Medication Prescription Redemption and Socioeconomic Status in Hungary in 2016: A Cross-Sectional Study

• Main Authors: Attila Juhász, Csilla Nagy, Orsolya Varga, Klára Boruzs, Mária Csernoch, Zoltán Szabó, Róza Ádány
• Format: Article
• Language: English
• Published: MDPI AG 2020-09-01
• Series: International Journal of Environmental Research and Public Health
• Subjects: deprivation; socioeconomic status; preventive medication; drug prescription; redemption rate; cardiovascular disease burden
• Online Access: https://www.mdpi.com/1660-4601/17/18/6855
• ISSN: 1661-7827; 1660-4601

This work was designed to investigate antithrombotic drug utilization and its link with the socioeconomic characteristics of specific population groups in Hungary by a comparative analysis of data for prescriptions by general practitioners and the redeemed prescriptions for antithrombotic drugs. Risk analysis capabilities were applied to estimate the relationships between socioeconomic status, which was characterized by quintiles of a multidimensional composite indicator (deprivation index), and mortality due to thromboembolic diseases as well as antithrombotic medications for the year 2016 at the district level in Hungary. According to our findings, although deprivation is a significant determinant of mortality due to thromboembolic diseases, clusters can be identified that represent exemptions to this rule: an eastern part of Hungary, consisting of two highly deprived counties, had significantly lower mortality than the country average; by contrast, the least-deprived northwestern part of the country, consisting of five counties, had significantly higher mortality than the country average. The fact that low socioeconomic status in general and poor adherence to antithrombotic drugs irrespective of socioeconomic status were associated with increased mortality indicates the importance of more efficient control of preventive medication and access to healthcare in all districts of the country to reduce mortality due to thromboembolic diseases.